Envista Holdings Corporation (NVST) Market Cap & Valuation Ratios
Envista Holdings Corporation (NVST) has a market cap of $3.8B, a trailing P/E of 40.7 and a price-to-sales ratio of 1.3, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason
- Market cap
- 3.8B
- P/E TTM
- 40.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Peers
medical instruments & supplies · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| NVST | 3.8 | 40.7 | 1.4 | 10.5 | 6.5% | +12% | 10% | 3% |
| BLCO | 6.2 | — | 2.1 | 15.0 | 2.2% | +9% | 6% | 2% |
| TFX | 5.8 | — | 3.7 | 43.0 | 2.9% | +31% | 2% | 0.6% |
| MMSI | 5.6 | 38.4 | 3.7 | 18.0 | 3.6% | +10% | 13% | 8% |
| MMED | 5.2 | — | 1.5 | — | -6.1% | +14% | -5% | -5% |
| MMEDV | 5.0 | — | — | — | — | +14% | -5% | -5% |
| ICUI | 4.2 | — | 2.4 | 18.7 | 3.7% | -9% | 3% | 1% |
| PLSE | 3.8 | — | — | — | -1.6% | — | — | — |
| WRBY | 3.2 | — | 3.2 | 52.9 | 0.7% | +11% | 0.2% | 1% |
| ATRC | 3.0 | — | 5.1 | 85.7 | 1.8% | +14% | 2% | 3% |
| LMAT | 1.9 | 29.6 | 6.6 | 19.6 | 3.8% | +12% | 29% | 11% |
| Median of these 10 | 34.0 | 3.4 | 19.6 | 2.2% | +12% | 2% | 1% |
P/E 40.7 vs. a peer median of 34.0; EV/Sales 1.4 vs. 3.4. NVST's own P/E sits at the 66th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesBLCO and TFX and MMED and MMEDV and ICUI and PLSE and WRBY and ATRC have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Envista Holdings Corporation — questions
- What is Envista Holdings Corporation's market cap?
- $3.8B.
- What is Envista Holdings Corporation's P/E ratio?
- 40.7 on trailing twelve-month earnings to 2026-07-03.
- What is Envista Holdings Corporation's price-to-sales ratio?
- 1.3.
Every figure on this page comes from Envista Holdings Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.